These generic versions of carboplatin 10mg/ml injections packed in 5ml, 15ml and 45ml single use vials are bioequivalent to Paraplatin injections distributed by Bristol Myers Squibb Oncology/Virology.
Carboplatin injections are indicated as initial and secondary therapy in patients with advanced ovarian carcinoma.